WHAT DRIVES AN ADDICT?
Source: UC Berkeley
What drives addicts to repeatedly choose drugs, alcohol, cigarettes,
overeating, gambling or kleptomania, despite the risks involved?
Neuroscientists at the University of California, Berkeley, have pinpointed
the exact locations in the brain where calculations are made that can
result in addictive and compulsive behavior.
UC Berkeley researchers have found how neural activity in the brain's
orbitofrontal and anterior cingulate cortex regulates our choices. These
astonishing new findings could pave the way for more targeted treatments
for everything from drug and alcohol abuse to obsessive-compulsive disorders.
'The better we understand our decision-making brain circuitry, the
better we can target treatment, whether it's pharmaceutical, behavioral
or deep brain stimulation," said Jonathan Wallis, associate professor
of psychology and neuroscience at UC Berkeley and the principal investigator
of the study published in the Oct. 30 online issue of the journal Nature
Neuroscience.
Wallis was inspired to look into the brain mechanism behind substance
abuse when he observed the lengths to which addicts will go to fulfill
their cravings, despite the downside of their habit: He asked, "What
has the drug done to their brains that makes it so difficult for them
not to make that choice? What is preventing them from making the healthier
choice?"
In the new study, he and fellow researchers targeted the orbitofrontal
cortex and anterior cingulate cortex - two areas in the frontal brain
- because previous research has shown that patients with damage to these
areas of the brain are impaired in the choices they make. While these
individuals may appear perfectly normal on the surface, they routinely
make decisions that create chaos in their lives. A similar dynamic has
been observed in chronic drug addicts, alcoholics and people with obsessive-compulsive
tendencies.
"They get divorced, quit their jobs, lose their friends and lose
all their money," Wallis said. "All the decisions they make
are bad ones."
To test their hypothesis that these areas of the brain were the key
players in impaired decision making, the UC Berkeley researchers measured
the neural activity of macaque monkeys as they played games in which
they identified the pictures most likely to deliver juice through a
spout into their mouths.
The animals quickly learned which pictures would most frequently deliver
the greatest amount of juice, enabling researchers to see what calculations
they were making, and in which part of the brain. The brains of macaques
function similarly to those of humans in basic decision making. The
exercise was designed to see how the animals weigh costs, benefits and
risks.
The results show that the orbitofrontal cortex regulates neural activity,
depending on the value or "stakes" of a decision. This part
of the brain enables you to switch easily between making important decisions,
such as what school to attend or which job to take, and making trivial
decisions such as coffee versus tea or burrito versus pizza. However,
in the case of addicts and people with damage to the orbitofrontal cortex,
the neural activity does not change based on the gravity of the decision,
presenting trouble when these individuals try to get their brains in
gear to make sound choices, the findings suggest.
As for the anterior cingulate cortex, the study found that when this
part of the brain functions normally, we learn quickly whether a decision
we made matched our expectations. If we eat food that makes us sick,
we do not eat it again. But in people with a malfunctioning anterior
cingulate cortex, these signals are missing, and so they continue to
make poor choices, Wallis said.
PAIN KILLER DEATHS TRIPLE!



Source: Center for disease control and prevention
New numbers released show the number of Americans who died from overdoses
of prescription painkillers more than tripled in the past decade, according
to the Centers for Disease Control and Prevention. More people now die
from painkillers than from heroin and cocaine combined. For every person
who died of a prescription painkiller overdose in 1999, nearly four
died in 2008. We are in the midst of an epidemic, says Grant Baldwin
of the CDC in a recent interview. An estimated 14,800 people died in
the United States from painkiller overdoses in 2008, a more than threefold
jump from the 4,000 deaths recorded in 1999. The CDC said painkiller
abuse and deaths are rising because the drugs are easier than ever to
obtain. They cited the growth of “pill mills,” clinics that
prescribe opioids without first conducting medical exams, and “doctor
shopping,” or receiving multiple prescriptions from different
doctors.
According to the CDC, enough painkillers were prescribed in 2010 to
medicate every American adult around the clock for a month.
ADOLESCENTS AND AMPHETAMINES
Source: Science Daily
Amphetamine use in adolescence can cause neurobiological imbalances
and increase risk-taking behavior, and these effects can persist into
adulthood, even when subjects are drug free. These are the conclusions
of a new study using animal models conducted by McGill University Health
Centre (MUHC) researcher Dr. Gabriella Gobbi and her colleagues. The
study, published in The International Journal of Neuropsychopharmacology,
is one of the first to shed light on how long-term amphetamine use in
adolescence affects brain chemistry and behavior. Amphetamine is a psychostimulant
drug which produces increased wakefulness and focus, in association
with decreased fatigue and appetite. This drug, commonly known as "speed,"
is also used recreationally and as a performance enhancer. According
to the United Nations Office on Drugs and Crime (UNODOC) report (2011),
more than 10 per cent of adolescents in the U.S. have used amphetamines.
In Europe, between two and seven per cent of adolescents have tried
amphetamines, and in Canada the number is estimated at just over five
per cent.
Study subjects were given one of three dosing regimens of amphetamine
during adolescence. When they reached adulthood, drugs were withdrawn
and their neurophysiological activity and risk-taking behaviour were
studied. "We focused on the key neurotransmitters serotonin, dopamine
and norepinephrine," Dr. Gobbi explains. "We found abnormalities
in brain activity associated with all three of these neurochemicals,
called "monoamines." Imbalances of monoamines are associated
with emotional disturbances and mental diseases such as depression or
addiction."
Researchers also noted behavioral changes in all dosing groups. Hyperactivity
was observed in rodents exposed to a moderate dose of amphetamine during
adolescence, while risk-taking behavior increased in every dosage group.
"Obviously we have to be very cautious about applying these results
to a human population," says Dr. Gobbi. "However, given the
basic similarities between human and rodent brains, these results are
cause for concern. They suggest that the effects of amphetamine use
can persist into adulthood, even if the subject is no longer taking
drugs, and that these effects include a tendency toward risk-taking
behavior."
NICOTINE-THE GATEWAY DRUG
Source: NIDA
A landmark study in mice identifies a biological mechanism that could
help explain how tobacco products could act as gateway drugs, increasing
a person's future likelihood of abusing cocaine and perhaps other drugs
as well, according to the National Institute on Drug Abuse (NIDA), part
of the National Institutes of Health. The study is the first to show
that nicotine might prime the brain to enhance the behavioral effects
of cocaine. The gateway drug model is based upon epidemiological evidence
that most illicit drug users report use of tobacco products or alcohol
prior to illicit drug use. This model has generated significant controversy
over the years, mostly relating to whether prior drug exposure (to nicotine,
alcohol or marijuana) is causally related to later drug use. Before
now, studies have not been able to show a biological mechanism by which
nicotine exposure could increase vulnerability to illicit drug use.
In the current study, by researchers at Columbia University, New York
City, and published in Science Translational Medicine, mice exposed
to nicotine in their drinking water for at least seven days showed an
increased response to cocaine. This priming effect depended on a previously
unrecognized effect of nicotine on gene expression, in which nicotine
changes the structure of the tightly packaged DNA molecule, reprograms
the expression pattern of specific genes, in particular the FosB gene
that has been related to addiction, and ultimately alters the behavioral
response to cocaine.
To examine whether the results from this study paralleled findings in
humans, the researchers reexamined statistics from the 2003 National
Epidemiological Study of Alcohol Related Consequences to explore the
relationship between onset of nicotine use and degree of cocaine dependence.
They found that the rate of cocaine dependence was higher among cocaine
users who smoked prior to starting cocaine compared to those who tried
cocaine prior to smoking.
These findings in mice suggest that if nicotine has similar effects
in humans, effective smoking prevention efforts would not only prevent
the negative health consequences associated with smoking but could also
decrease the risk of progression and addiction to cocaine and possibly
other illicit drug use. In the meantime, this mouse model provides a
new mechanism to study the gateway theory from a biological perspective.
1 IN 4 AMERICANS BINGE DRINKING!
Source: National Survey on Drug Use and Health
Almost one-quarter of Americans age 12 or older say they participated
in binge drinking in the previous month, according to a government survey.
The National Survey on Drug Use and Health found binge drinking rates
varied among states, ranging from 14.1 percent in Utah, to 29.8 percent
in North Dakota. The survey defines binge drinking as having five or
more drinks on one occasion.
The survey also found 8.4 percent of Americans have used an illegal
drug in the previous month, USA Today reports. The survey, released
by the Substance Abuse and Mental Health Services Administration (SAMHSA),
found that 9.7 percent of teens ages 12 to 17 had used illegal drugs
in the past month. In the past year, 10.8 percent of Americans reported
using marijuana, and 6.4 percent used the drug in the previous month.
The survey included interviews with more than 137,000 people between
2008 and 2009.
Alaska had the highest rate of illegal drug use (13.5 percent), while
Iowa had the lowest rate (5.3 percent). Kentucky had the largest percentage
of smokers (32 percent); Utah had the smallest (16.4 percent). Oklahoma
had the highest rate of people using pain relievers for non-medical
reasons in the past year (8.1 percent); Iowa and Nebraska had the lowest
rate (3.6 percent).
“No state is free from the unique impact of mental and substance
use disorders,” SAMHSA Administrator Pamela S. Hyde, J.D., said
in a news release. “Data like these give states the information
they can use to target their prevention and treatment activities for
the greatest benefit to their residents.”
CHANTIX-
NEW RESEARCH ABOUT NICOTINE REPLACEMENT THERAPY
Source: PLoS ONE
The poor safety profile of the smoking-cessation drug varenicline (Chantix™)
makes it unsuitable for first-line use, according to a recent study.
Varenicline, which already carries a "black box warning" from
the U.S. Food and Drug Administration (FDA), showed a substantially
increased risk of reported depression or suicidal behavior compared
to other smoking-cessation treatments, according to researchers at Wake
Forest Baptist Medical Center, the Institute for Safe Medication Practices,
Harvard Medical School and Johns Hopkins University School of Medicine.
The researchers found that 90 percent of all reported suicides related
to smoking- cessation drugs since 1998 implicated varenicline, even
though it was on the market only four years in the nearly 13-year study
period. They also found that varenicline was eight times more likely
to result in a reported case of suicidal behavior or depression than
nicotine replacement products.
"Our study contradicts the implications of a recent review by the
FDA showing no difference in psychiatric hospitalizations between varenicline
and nicotine replacement patches," said Curt D. Furberg, M.D.,
Ph.D., professor of Public Health Sciences at Wake Forest Baptist, co-author
of the study and a nationally recognized leader in drug safety research.
"The FDA hospitalization studies were flawed because they could
not capture most of the serious psychiatric side effects, including
suicide, depression, aggression and assaults. These can be catastrophic
events but do not normally result in hospitalization.
"We found that Chantix is associated with more suicidal behavior
reports than any other smoking-cessation drug on the U.S. market. The
risks simply outweigh the benefits."
$600 MILLION SPENT ON TOBACCO



Source: FDA
The U.S. Food and Drug Administration (FDA) will spend about $600 million
over five years on a campaign to educate the public about the dangers
of tobacco. The first part of the campaign will target groups including
youth, minorities, the military, the gay community and people with disabilities,
Dr. Lawrence Deyton, Director of the FDA’s Center for Tobacco
Products stated in a recent interview. The campaign will include ads
on TV and in print, and will use social media including Facebook, Twitter
and YouTube.
Deyton said the FDA hopes to reduce the smoking rate in the United States,
which has been stalled at about 20 percent since 2004. “One of
the big lessons that I’ve learned is that we might have great
public health programs, but they will fail if we do not adequately educate
the public about them,” he said.
The campaign will be paid for through fees the FDA is charging tobacco
companies. Fees are collected based on each company’s share of
the U.S. tobacco market. They were imposed as part of the 2009 Family
Smoking Prevention and Tobacco Control Act, which gives the FDA authority
to regulate the content, marketing and sale of tobacco products. The
FDA hopes the first campaign will appear at the same time as the new
warning labels on cigarette packs in the fall of 2012. The labels will
carry graphic images of the consequences of smoking, including diseased
lungs and rotting teeth.
EFFECTIVE ADDICTION TREATMENT
Source: Medical News Today
Portuguese researchers have discovered that rats exposed before birth
to glucocorticoids (GC) not only show several brain abnormalities similar
to those found in addicts, but become themselves susceptible to addiction
(the glucorticoids, which are stress hormones, were used to mimic pre-natal
stress). But even more remarkable, Ana João Rodrigues, Nuno Sousa
and colleagues were able to reverse all the abnormalities (including
the addictive behavior) by giving the animals dopamine (a neurotransmitter/
brain chemical).
The study has several implications for a start it alerts for the dangers
of high levels of stress during pregnancy, but - since GC are often
prescribed as an anti-inflammatory or to help organ maturation during
pregnancy - it also calls for an urgent investigation on the effects
of this drug in pregnant women. But it is what we learn about addiction
that is most interesting - the work not only unveils stress as a new
susceptibility factor for the disease, but also a very simple treatment
that, if translated into humans, could one day mean an effective treatment,
and maybe even the prevention of human addiction.
Drug addiction was for a long time a character flaw, a moral problem.
Now, instead, is accepted as the complex brain disease that is with
the addict a patient in need of treatment. After all many people try
drugs, but only a few become addicts
And it is in these few that lays the key to the disease and its treatment.
So what do we know about these patients and the disease? First although
the psychological and social contexts in which the drug is taken are
important, as much as 50% of the compulsion is in the individual's genetic
makeup. We know that addiction is linked to the mesolimbic system -
the brain area that evolved to provide feelings of pleasure to actions
that increase our survival chances, such as eat, sex and social stimulation.
In fact, drugs activate the mesolimbic circuit too, only far stronger
than any physiologic stimulus. This leads to the production of very
high quantities of dopamine the brain chemical linked to pleasure creating
the euphoria that brings users back. After while, though, the brain
no longer can cope with the constant " high" and adapts by
becoming desensitised to dopamine (produced by any type of stimulus)
what leads users to consume more in order to "feel" again
and trapping those more susceptible in addiction. And with the brain
changes induced by drugs being apparently long-lasting - since both
cravings and relapses don't disappear with time it is not easy to escape
once trapped.
Adding another piece to the puzzle, recently the disease was also linked
to stress during crucial developmental periods, such as feotal life.
In fact, high levels of prenatal stress increase propensity to mental
problems and now have been suggested also to substance abuse, with the
effects being mediated by glucocorticoids (GC).
Rodrigues and Sousa's group have a long history of interest in stress
and have seen before that rats from mothers injected with GC while pregnant
(mimicking pre-natal stress) show changes in their mesolimbic area and
in the dopamine response. So in the study now published, following these
results and the addiction-stress link, the researchers investigated
the responses to drugs in rats exposed to GC while in the uterus. These
rats were found to have a susceptibility to addiction not present in
control (non-exposed) rats.
When their mesolimbic system was examined they also showed several
structural and molecular abnormalities, including less dopamine. The
levels of their dopamine receptor Drd2, despite initially being very
high, once they experimented drugs, went to abnormally low levels .
So why is this important? Because reduced dopamine and Drd2 levels are
typical of addicts suggesting that stress and long-term exposure to
drugs affect the brain in very similar ways what could explain why the
first could lead to the second.
The good news is that low levels of dopamine can be treated so Rodrigues
and colleagues restored the rats' dopamine levels to normal just to
find,much to their surprise, that all the structural and molecular abnormalities
induced by prenatal GC were reversed. Even more surprising, the addictive
behavior also disappeared.
As Ana João Rodrigues explains, "This is a remarkable result
because it suggests that with a relatively simple pharmacological approach-
restoration of dopamine levels- we can eventually treat, and even more
importantly, potentially prevent drug abuse in vulnerable individuals.
Of course that we still have a long way to go but our results are quite
promising. In fact, if we know where susceptibility to substance abuse
lies and low dopamine and altered Drd2 response seems to be it - then
maybe we can find better ways to prevent/treat this disorder. "
Restoring dopamine levels has been used to treat cocaine cravings but
the few trials looking at its effect on addiction were never very clear.
One possible reason might be the length or the dosages used in Rodrigues'
study, rats treated for 3 days reverted back to an addictive behavior
3 weeks after the end of the treatment, but this no longer occurs if
the treatment continues for 3 weeks.
Drug abuse and addiction carry enormous social and financial costs
to society, families and individuals. Only in the US, the National Institute
for Drug Abuse calculates that more than 600 billion dollars are being
spent, annually, to combat the disease.
ATTENTION SMOKERS-
Source: Science Daily
Scientists now understand more about why being exposed to nicotine while
you were a fetus will increase your risk of developing cardiovascular
disease as an adult. "We have found distinct links between cigarette
smoking or even using nicotine patches or gum and the long-term harm
for the child," says Dr. DaLiao Xiao, a scientist who works at
the Loma Linda University School of Medicine in California. Publishing
their research in the British Journal of Pharmacology, Xiao and colleagues
showed that when he gave nicotine to pregnant rats, the offspring had
higher risks of high blood pressure than animals whose mothers didn't
receive nicotine during pregnancy. While the work was carried out in
rats, these findings fitted well with studies carried out in people.
Importantly, the researchers have discovered that specific changes in
the blood vessel walls account for this outcome. The study shows that
nicotine causes the formation of chemicals, known as reactive oxygen
species (ROS), in the walls of blood vessels in the fetus. These ROS
cause permanent changes that alter the normal behaviour of the blood
vessel. This faulty programming is then carried throughout the individual's
life and may lead to high blood pressure in adults.
"Other researchers have shown that cigarette smoking or nicotine
use in pregnant women results in an increased risk of hypertension and
cardiovascular disease in adulthood. Our findings provide novel information
of the fetal programming that links fetal nicotine exposure to the long
term damage," says Xiao.
In a commentary accompanying the paper, Rebecca Lim, of The Ritchie
Centre, Monash Institute of Medical Researc, and Associate Professor
Christopher Sobey, of the Department of Pharmacology, Monash University,
Australia, state: "If this is ultimately proven in humans, this
important work will have revealed a novel cardiovascular risk factor
that can only be modified before birth."
CAREFUL WITH YOUR SCRIPTS-
SOURCE: DREXEL UNIVERSITY
A new study by researchers at Drexel University's School of Public Health
suggests that abuse of prescription painkillers may be an important
gateway to the use of injected drugs such as heroin, among people with
a history of using both types of drugs. The study, published in the
International Journal of Drug Policy, explores factors surrounding young
injection drug users' initiation into the misuse of opioid drugs. Common
factors identified in this group included a family history of drug misuse
and receiving prescriptions for opioid drugs in the past. The results
support a need for efforts to prevent misuse of prescription drugs,
particularly during adolescence.
"Participants were commonly raised in household where misuse of
prescription drugs, illegal drugs, or alcohol, was normalized,"
explains Dr. Stephen Lankenau, an associate professor in the School
of Public Health and principal investigator of the study. "Access
to prescription medications -- either from a participant's own source,
a family member, or a friend -- was a key feature of initiation into
prescription drug misuse."
In numerous cases, the desire to experiment with a prescription opioid
drug (the common class of drugs that includes codeine and oxycodone),
combined with financial incentives or pressures from friends to sell
available quantities, resulted in escalated patterns of opioid misuse,
according to the study.
Lankenau and colleagues also describe two key findings as evidence of
an emerging dynamic among misuse of opioid drugs and the use of injection
drugs. First, four of five IDUs misused an opioid before injecting heroin,
in contrast to more conventional patterns of using opioids as a substitute
drug after initiating heroin use.
Second, in nearly one out of four young IDUs in this study, a prescription
opioid was the first type of drug they injected. Prescription opioids
are rarely reported at initiation into injection drug use amongst young
IDUs. All but two of these participants later transitioned into injecting
heroin.
Opioid misuse is an important public health concern due to the increasing
association of opioids with drug dependence and fatal overdose, and
much research has focused on the factors affecting how and when people
initially misuse opioids. However, descriptive data about initiation
into prescription opioid misuse among young injection drug users are
scarce.
To fill this gap, in this study researchers interviewed 50 young IDUs
aged 16 and 25 years old in New York and Los Angeles, who had misused
a prescription drug at least three times in the past three months, to
study contextual factors leading to their use of opioid drugs. Participants
were recruited in natural settings, such as parks, streets, and college
campuses, during 2008 and 2009. A mixed-methods research design was
utilized that collected both quantitative and qualitative data.
Additional findings and descriptors of the study population include:
Most were white, heterosexual males in their early 20s
Many did not complete high school, were expelled from school, or held
back a grade
Nearly all were homeless at some point, most were currently homeless,
and most regarded themselves as "travelers," (i.e., moving
from city to city in search of work, housing, or adventure)
Most had received a psychological diagnosis, such as depression, anxiety,
or Attention Deficit Hyperactivity Disorder (ADHD), and many had a history
of drug treatment
Most generally regarded prescription opioids as readily accessible,
valued commodities that could be traded or sold
Nearly three-quarters had been prescribed an opioid in their lifetime,
which occurred on average at 14.6 years old, often for common ailments
such as dental procedures or sports injuries
Most witnessed family members misuse one or more substances during childhood
and adolescence, ranging from alcoholism to injecting heroin
The authors conclude that prevention efforts, especially during adolescence,
are needed, and that parents and guardians need to carefully monitor
and safeguard all prescription medications, particularly opioids, within
the household. Although households where drug use is normalized or where
broader social or psychological problems exist are more difficult to
remedy with prevention efforts or policy changes, future research examining
prescription opioid misuse among a range of adolescents and young adults
to better understand the contextual and environmental factors of drug
use may yield additional solutions.
The article was co-authored by Karol Silva (Drexel University); Michelle
Teti (University of Missouri); Alex Harocopos (National Development
and Research Institutes); and Jennifer Jackson Bloom and Meghan Treese
(Children's Hospital Los Angeles).
Lankenau is also principal investigator of two studies evaluating the
effectives of overdose prevention programs in Los Angeles and Philadelphia.
Lankenau is an associate professor in the Department of Community Health
& Prevention at the Drexel University School of Public Health. He
received his PhD and MA degrees in Sociology from the University of
Maryland. He earned his BA in Sociology at the University of Vermont.
DENTISTS OR DEALERS
Source: Journal of American Dental Association
The Obama administration turned a bright spotlight on prescription painkiller
abuse in April when the Office of National Drug Control Policy released
a national action plan and a statement from Vice President Joe Biden.
With a cover article in the July edition of the Journal of the American
Dental Association (JADA), dentists focus that spotlight on themselves
both as major sources of opioid drugs and as professionals with largely
untapped power to recognize and reduce abuse.
Many dentists really haven't even perceived there to be a problem,"
said George Kenna, an assistant professor of psychiatry and human behavior
at the Warren Alpert Medical School of Brown University, an addiction
psychologist at the Center for Alcohol and Addiction Studies, and the
corresponding author of the article. "Dentists write the third-most
prescriptions for immediate release opioids in the United States, but
they often don't know the appropriate number of doses to prescribe,
how many doses a patient uses, or most importantly what patients do
with the leftover tablets they have. Just ask someone the last time
they threw away opioid prescriptions in particular. These leftover tablets
-- accumulated from various sources, not just dentists -- that are often
left in closets across the country are the primary source for prescription
drug use initiation for children and adolescents."
As outlined by the administration's policy, facilitating ways to reduce
the number of leftover painkillers such as hydrocodone and oxycodone
that can become a supply of drugs in the home for those who would abuse
them, dentists and other prescribers would be taking a significant step,
said Kenna who is also a pharmacist. The National Survey on Drug Use
and Health has found that seven in 10 people who have used painkillers
nonmedically got the drugs through a family member or friend who had
a prescription.
Last year Kenna helped lead a meeting of dentists and fellow addiction
experts and pharmacists at the Tufts Health Care Institute Program on
Opioid Risk Management, where he serves as a scientific adviser. The
group produced this month's cover article for JADA, which offered several
recommendations for dentists, including:
Discuss with patients whether they need an opioid for their pain and
how likely they are to use what you prescribe.
Consider writing small quantities and limit refills.
Do not prescribe drugs to patients you do not know; be suspicious of
those who claim their drugs were lost or stolen.
Use prescription monitoring programs (i.e., state databases), if available,
to verify drug-use history.
Advise patients either to destroy or lockup any excess medication.
Keep prescription pads locked up.
In the article, the nine authors also call for more research to make
the most effective use of opioid and non-opioid painkillers, for instance
to determine how much painkiller and which kind patients really need.
Without enough evidence to guide them, dentists have often felt obliged
to prescribe opioids too often and in too great a quantity, Kenna said.
"Some new data show that ibuprofen as an anti-inflammatory does
as well as many painkillers to kill pain for many dental procedures,"
Kenna said.
Despite the large role dentists have as painkiller prescribers, there
has been very little research on dentists' prescribing practices and
experiences, particularly in the context of opioid addiction. To inform
their discussion, the group commissioned a survey in 2010, led by Michael
O'Neil, a pharmacy professor at the University of Charleston in West
Virginia. In all, 52 percent of the state's dentists responded.
The survey revealed that nine in 10 of the dentists surveyed prescribed
opioids in the prior year. Two-thirds prescribed between 10 and 20 doses
of the painkillers, but 41 percent acknowledged that patients would
probably have some left over.
The survey also found some evidence that dentists can sometimes be shy
about raising substance abuse as an issue with patients, even as they
realize they are sometimes being used to get drugs. One in three of
the dentists said they did not routinely ask new patients about substance
abuse, but 58 percent of the dentists said they believed they have been
the victim of prescription fraud or theft.
While dentists should guard against over-prescribing addictive drugs,
especially to patients they don't know well, Kenna said, they retain
an obligation to help all patients, even ones who are addicted, to manage
pain.
"There are ways that dentists can work with patients," he
said. "People who have a substance abuse problem do have legitimate
pain. They do have a right to have some pain control and may even need
more. But you hope there is a family member who will take control and
make sure they only take the recommended dose."
For all the things dentists could do, especially with more research
to clarify the best prescribing practices, Kenna acknowledged that dentists
are not currently compensated for the time required to investigate the
drug use preferences and habits of their patients.
Kenna said he hopes to learn more about how the profession approaches
opioids and addiction with a national survey of dentists.
"It's a growing problem in the United States," he said. "It's
a serious problem."
HOPE FOR COCAINE ADDICTION
Source: Medical News Today
New discoveries by researchers at the University of Wisconsin-Milwaukee
(UWM) offer potential for development of a first-ever pharmacological
treatment for cocaine addiction.
A common beta blocker, propranolol, currently used to treat people with
hypertension and anxiety, has shown to be effective in preventing the
brain from retrieving memories associated with cocaine use in animal-addiction
models, according to Devin Mueller, UWM assistant professor of psychology
and a co-author with James Otis of the research.
This is the first time that a therapeutic treatment has been shown to
block the retrieval of memories associated with drug addiction, a major
reason many addicts experience relapse, says Mueller.
The research is published in the August issue of the journal Neuropsychopharmacology
("Inhibition of ß-Adrenergic Receptors Induces a Persistent
Deficit in Retrieval of a Cocaine-Associated Memory Providing Protection
against Reinstatement.")
Cocaine is one of the worst drug addictions to kick, with about 80 percent
of those trying to quit experiencing a relapse within six months.
"Right now, there are no FDA-approved medications that are known
to successfully treat cocaine abuse," says Mueller, "only
those that are used to treat the symptoms of cocaine withdrawal, which
are largely ineffective at preventing relapse."
The effects of propranolol were long-lasting and could be permanent,
he says, even without subsequent doses and even in the presence of stimuli
known to induce relapse.
Currently, "exposure therapy" is used to help recovering addicts
suppress their drug-seeking behavior. In this therapy, the patient is
repeatedly exposed to stimuli that provoke cravings but do not satisfy
them. Done repeatedly over time, the patient experiences less craving
when presented with those stimuli.
The success of exposure therapy, however, is limited. Combining therapy
with the use of propranolol, says Mueller, would boost the effectiveness
of the treatment.
Propranolol was chosen for the memory study because it has been used
before to ease some withdrawal symptoms experienced by recovering cocaine
addicts. Those using the drug were able to continue exposure therapy
for longer periods than those without the drug.
But Mueller adds that propranolol has never been tested for use with
memory extinction before.
In order to develop a drug treatment for overcoming relapse, the next
step in the research is to determine where in the brain propranolol
acts to mediate the retrieval of cocaine-associated memories.
ALMOST A QUARTER OF ALL AMERICANS BINGE DRINKING!
Source: National Survey on Drug Use and Health
Almost one-quarter of Americans age 12 or older say they participated
in binge drinking in the previous month, according to a government survey.
The National Survey on Drug Use and Health found binge drinking rates
varied among states, ranging from 14.1 percent in Utah, to 29.8 percent
in North Dakota. The survey defines binge drinking as having five or
more drinks on one occasion.
The survey also found 8.4 percent of Americans have used an illegal
drug in the previous month, USA Today reports. The survey, released
by the Substance Abuse and Mental Health Services Administration (SAMHSA),
found that 9.7 percent of teens ages 12 to 17 had used illegal drugs
in the past month. In the past year, 10.8 percent of Americans reported
using marijuana, and 6.4 percent used the drug in the previous month.
The survey included interviews with more than 137,000 people between
2008 and 2009.
Alaska had the highest rate of illegal drug use (13.5 percent), while
Iowa had the lowest rate (5.3 percent). Kentucky had the largest percentage
of smokers (32 percent); Utah had the smallest (16.4 percent). Oklahoma
had the highest rate of people using pain relievers for non-medical
reasons in the past year (8.1 percent); Iowa and Nebraska had the lowest
rate (3.6 percent).
“No state is free from the unique impact of mental and substance
use disorders,” SAMHSA Administrator Pamela S. Hyde, J.D., said
in a news release. “Data like these give states the information
they can use to target their prevention and treatment activities for
the greatest benefit to their residents.”
IV Drug Users
Source: Medical News Today
Botulism is a rare disease and recurrent botulism even more rare. However,
in California, recurrent wound botulism among injection drug users has
been on the rise and makes up three-quarters of reported cases in the
United States. From 1993 through 2006, 17 injection drug users were
identified within the surveillance system of the California Department
of Public Health for having recurrent wound botulism. Clinical symptoms
ranged from acute paralysis to slurred speech to difficulty swallowing,
and at least one case of wound botulism for each patient was laboratory
confirmed. Of those, 14 had one recurrence and three had two recurrent
episodes. All of the patients reported heroin use, with 88 percent specifically
reporting black tar heroin use.
"Recurrent cases suggest that exposure to botulism due to injection
drug use does not result in protective immunity," according to
study author Duc Vugia, MD, of the California Department of Public Health.
"As a result, both clinicians and injection drug users should be
aware of the potential for wound botulism to recur with continued injection
drug use to allow for timely diagnosis and early administration of appropriate
treatment."
Dr. Vugia added, "If these near death experiences do not change
behavior among these injection drug users and if severe disease from
exposure to botulism does not confer immunity, recurrent wound botulism
will continue to occur and add to the health care burden. Continued
efforts to reduce injection drug use and educate current users on the
infectious risks associated with illicit drug use are crucial to improving
the health of the injection drug use population."
Link Between Victims and Substance Abuse
Source: University of IL. At Chicago
A strong link between victimization experiences and substance abuse
has been discovered by researchers at the University of Illinois at
Chicago. The correlation is especially prevalent among gays, lesbians
and bisexuals -- more so than in heterosexuals, says Tonda Hughes, professor
and interim head of health systems science in the UIC College of Nursing.
Hughes is lead author of the study, published in the journal Addiction.
Researchers compared victimization experiences of unwanted sexual activity,
neglect, physical violence, and assault with a weapon, across four sexual-identity
subgroups -- heterosexual, gay or lesbian, bisexual, or "not sure."
The study used data collected nationally from 34,635 adults from the
National Epidemiologic Survey on Alcohol and Related Conditions.
Hughes and her research team wondered if sexual-minority women and men
are at a heightened risk for victimization. The results, Hughes said,
showed that they are.
Lesbian and bisexual women were more than twice as likely as heterosexual
women to report any victimization over their lifetime. Lesbians, gay
men and bisexual women also reported a greater number of victimization
experiences than did heterosexuals. Three times as many lesbians as
heterosexual women reported childhood sexual abuse.
One possible explanation for this disproportionality, Hughes said, is
that lesbians are more willing to acknowledge and report this experience.
"Gays and lesbians tend to be more self-reflective," she said.
"This means they are more likely to think about and report negative
or stigmatizing life experiences. Heterosexuals may not be inclined
to do so."
Gay men also had high rates of victimization, with about half of them
reporting any lifetime victimization. They reported significantly higher
rates of childhood sexual abuse, childhood neglect, partner violence
and assault with a weapon than heterosexual men.
Not only are there higher rates of violence and victimization among
sexual minorities, but there is also a higher rate of substance abuse,
Hughes said.
Regardless of sexual identity, women who reported two or more victimization
experiences had two to four times the prevalence of alcohol dependence,
drug abuse or drug dependence as women who reported no victimization,
she said.
The research also concluded that gay, lesbian and bisexual youth may
use substances to cope with adverse psychological and interpersonal
effects of victimization, increasing the risk for further victimization
from others, she said.
The study was funded through grants from the National Institute on Drug
Abuse and the National Institute on Alcohol Abuse and Alcoholism, two
of the National Institutes of Health.
Drug Use and Your Health
Source: Journal of Medical Microbiology
Illicit drug users are at increased risk of being exposed to microbial
pathogens and are more susceptible to serious infections say physicians
writing in the Journal of Medical Microbiology. The review, which aims
to improve the microbiological diagnosis of drug use-related infections,
assesses the role of drug related practices in the spread of a range
of bacterial, viral, fungal and protozoal infections.
The review by collaborators from the Armed Forces Medical College, Pune,
India highlights convincing evidence that unsterile injection practices,
contaminated needles, syringes and the use of cutting agents all represent
avenues by which micro-organisms can enter the body. Outbreaks of tetanus,
Group A Streptococcal disease and, more recently, anthrax have all been
documented in illicit drug users.
Drug abuse not only enhances exposure to pathogens but can also increase
the risk of infection by facilitating the local growth of micro-organisms
and suppressing the user's overall immunity. Dr Karishma Kaushik one
of the authors, says, "Drugs such as cannabis and opiates have
been shown to directly suppress immune function. Methadone has also
been shown to enhance HIV replication in immune cells. What's more,
dead or damaged tissue at an injection site provides an ideal anaerobic
environment for certain pathogens to grow. The bacterial species Clostridia,
for example, thrive in anaerobic environments and can lead to wound
botulism, tetanus and necrotizing fasciitis - commonly known as the
flesh-eating disease."
The association between drug use and the transmission of certain viral
pathogens is well established. Illicit drug users represent the major
risk group for acquiring hepatitis C infection and also bear a substantial
burden of HIV infection globally. "Drug abuse accounts for at least
10% of HIV infections globally and this may rise to 40% in the near
future," explains Dr Kaushik. "Drug use also contributes to
the spread of HIV in non-drug user populations such as from injecting
husbands to their non-injecting wives. Associated lifestyle practices
such as multiple sexual partners are also co-factors in increasing the
risk of infection," she says.
Dr Kaushik believes that an increased awareness of the microbial complications
associated with drug use will allow better diagnosis and management
of infections in this group. "Infections are one of the most serious
complications of drug abuse. They are frequently encountered in the
hospital setting and constitute a major burden to the health care system.
Yet drug users are a relatively poorly studied cohort of patients seeking
clinical care."
Church, Clergy Helping Addicts
Source: Join Together/University of Michigan
About 15 percent of people seeking recovery from alcoholism turn to
clergy members for support, a University of Michigan study finds. A
survey of 1,910 individuals with alcohol-related problems found that
while many people seek help from clergy, most do so in conjunction with
professional services. Just 0.5 percent sought to recover through counseling
with a priest or other clergy member alone."Clergy are in a unique
position to notice changes in behavior over time," said study co-author
Brian Perron. "Their roles as senior leaders of churches, their
embodiment of important tenants of their faiths, and their formal roles
as caregivers of their congregations also lend clergy considerable credibility,
particularly within African-American communities. Clergy are often seen
as being deeply committed to their congregants and willing to honor
desires for confidentiality."
Watch What You Say!
Source: Science Daily
Stereotyping has a lasting effect. Aggression. Over-eating. Inability
to focus. Difficulty making rational decisions. New research out of
the University of Toronto Scarborough shows prejudice has a lasting
negative impact on those who experience it. "Past studies have
shown that people perform poorly in situations where they feel they
are being stereotyped," says Associate Professor of Psychology
Michael Inzlicht, who led the study, published in this month's edition
of the Journal of Personality and Social Psychology. "What we wanted
to do was look at what happens afterwards. Are there lingering effects
of prejudice? Does being stereotyped have an impact beyond the moment
when stereotyping happens?"
In order to determine whether negative stereotyping in a particular
situation had lasting effects, Inzlicht's team performed a series of
tests. First, they placed participants in situations where they had
to perform a task in the face of negative stereotyping. After the participants
were removed from the prejudicial situation, researchers measured their
ability to control their aggression, eat appropriate amounts, make rational
decisions, and stay focused.
Their results show that prejudice and stereotyping have lingering adverse
impacts.
"Even after a person leaves a situation where they faced negative
stereotypes, the effects of coping with that situation remain,"
says Inzlicht. "People are more likely to be aggressive after they've
faced prejudice in a given situation. They are more likely to exhibit
a lack of self control. They have trouble making good, rational decisions.
And they are more likely to over-indulge on unhealthy foods."
In one portion of the study, researchers had a group of women write
a math test. They told the women this test would determine whether or
not they were capable and smart in math, subtly injecting stereotypes
about women and math skills "into the air," says Inzlicht.
A separate group of women wrote the same test, except this group was
given support and coping strategies to deal with the stress they'd face
when writing the test.
After completing the math test, the two groups performed another series
of tasks designed to gauge their aggression levels, their ability to
focus and to exercise self control.
"In these follow-up tests, the women who felt discriminated against
ate more than their peers in the control group. They showed more hostility
than the control group. And they performed more poorly on tests that
measured their cognitive skills," says Inzlicht.
The pattern remained the same, regardless of the test groups. People
who felt they were discriminated against -- whether based on gender,
age, race or religion -- all experienced significant impacts even after
they were removed from the situation, says Inzlicht.
"These lingering effects hurt people in a very real way, leaving
them at a disadvantage," says Inzlicht. "Even many steps removed
from a prejudicial situation, people are carrying around this baggage
that negatively impacts their lives."
Editorial: I have long felt the power of words, the words we choose
can be crippling. As long as certain words remain acceptable we will
only be able to go so far with a recovery movement. Challenge yourself
to watch what you say, words hurt. When we place labels on people we
are only recognizing and identifying one single part of a bigger whole.
People in recovery themselves often do this as well identifying themselves
by first name followed by the word addict or alcoholic. Interestingly
enough I cannot recall my grandfather or anyone else for that matter
ever referring to himself as Cancer yet it’s also a progressive,
fatal disease if it goes untreated. Recovering people are so much more
than what they are addicted to/recovering from, they are mothers, fathers,
sisters, and our brothers so please reconsider your choice of words
before you open your mouth when having dialogue with a person suffering
with this disease called addiction. Furthermore when talking to anyone
in general because you never know who you are talking to, it may be
someone in need of help so don’t be an obstacle be the opportunity!
Teens And Their Internet…Addiction, Depression?
Source: MSNBC.COM/Reuters
HONG KONG — Teenagers who spend excessive amounts of time on
the Internet are one and a half times more likely to develop depression
than moderate web users, a study in China has found. Researcher Lawrence
Lam described some of the signs of excessive use spending at least five
to more than 10 hours a day on the Web, agitation when the teens is
not in front of the computer and loss of interest in social interaction."Some
spend more than 10 hours a day, they are really problematic users and
they show signs and symptoms of addictive behavior ... browsing the
Internet, playing games," said Lam, co-author of the paper which
was published on Tuesday in the Archives of Pediatrics & Adolescent
Medicine."They can't get their minds off the Internet, they feel
agitated if they don't get back on after a short period of being away,"
the psychologist at Sydney's University of Notre Dame's School of Medicine
said in a telephone interview."They don't want to see friends,
don't want to join family gatherings, don't want to spend time with
parents or siblings."
The study involved 1,041 teenagers aged between 13 and 18 years in China's
southern Guangzhou city who were free of depression at the start of
the investigation.Nine months later, 84 of them were assessed as suffering
from depression and those who were on the Internet excessively were
one-and-a-half times more vulnerable than moderate users."Results
suggested that young people who are initially free of mental health
problems but use the Internet pathologically could develop depression
as a consequence," wrote Lam, who co-authored the paper with Zi-wen
Peng at the Sun Yat-Sen University's School of Public Health in Guangzhou.The
depression might be a result of lack of sleep and stress from competitive
online games, he explained."People who spend so much time on the
Internet will lose sleep and it is a very well established fact that
the less one sleeps, the higher the chances of depression," Lam
said.Lam said this was the first study looking into pathological use
of the Internet as a possible cause for depression.A previous study
pointed to depression as a possible causal factor for Internet addiction,
while several other studies showed a link between the two without clearly
pointing which was the cause and which one the result.Lam called for
schools to screen students for Internet addiction, so they may receive
counseling and treatment.
New Report Pinpoints Substance Abuse Across The Country
Source: Medical News Today/SAMHSA
A new report shows that behavioral health problems affect every community
throughout America but in unique, and sometimes surprising ways. The
report, based on a nationwide survey commissioned by the Substance Abuse
and Mental Health Services Administration (SAMHSA), offers detailed
analyses of the substance use problems occurring within these smaller
geographical areas.
Since various regions of a state can experience significantly different
types of behavioral health problems this type of information is helpful
in targeting behavioral health services to where they are most needed.
For example, in Ohio alcohol use disorders range from 6.4 percent in
a region in the south central part of the state (Adams, Fayette, Gallia,
Highland, Jackson, Lawrence, Meigs, Pickaway, Pike, Ross, and Scioto
counties) to 9.5 percent in Franklin County.
"This report provides insight into the different behavioral health
needs of communities across the nation," SAMHSA Administrator Pamela
S. Hyde, J.D. said. "States and communities can use the data to
inform and target the delivery of prevention and treatment services
to meet their unique needs."
The report was developed as part of the agency's strategic initiative
on prevention as well as data, outcomes, and quality an effort to create
an integrated data strategy that informs policy makers and service providers
on the nature and scope of behavioral health issues.
Entitled, Substate Estimates from the 2006-2008 National Surveys on
Drug Use and Health, the report measures and analyzes 21 substance use
behaviors in 344 substate regions representing all 50 states and the
District of Columbia. In most states, the substate regions are defined
in terms of counties or groups of counties. In a few states, these areas
are defined in terms of census tracts, parishes (in Louisiana), or boroughs/census
areas (in Alaska).
The report's results were based on the combined data from the 2006 to
2008 National Surveys on Drug Use and Health (NSDUH) and involved responses
from more than 200,000 people age 12 or older throughout the United
States.
The Power Of Perceptions
Source: Wake Forest University
So is the glass half empty or half full? Is it an obstacle or and opportunity
for growth? Do you see things as problems or challenges? A new study
has shed some light on how the power of perceptions in particular your
own relates to your happiness.
"Your perceptions of others reveal so much about your own personality,"
says Dustin Wood, assistant professor of psychology at Wake Forest and
lead author of the study, about his findings. By asking study participants
to each rate positive and negative characteristics of just three people,
the researchers were able to find out important information about the
rater's well-being, mental health, social attitudes and how they were
judged by others.
The study appears in the July issue of the Journal of Personality and
Social Psychology. Peter Harms at the University of Nebraska and Simine
Vazire of Washington University in St. Louis co-authored the study.
The researchers found a person's tendency to describe others in positive
terms is an important indicator of the positivity of the person's own
personality traits. They discovered particularly strong associations
between positively judging others and how enthusiastic, happy, kind-hearted,
courteous, emotionally stable and capable the person describes oneself
and is described by others.
"Seeing others positively reveals our own positive traits,"
Wood says.
The study also found that how positively you see other people shows
how satisfied you are with your own life, and how much you are liked
by others.
In contrast, negative perceptions of others are linked to higher levels
of narcissism and antisocial behavior. "A huge suite of negative
personality traits are associated with viewing others negatively,"
Wood says. "The simple tendency to see people negatively indicates
a greater likelihood of depression and various personality disorders."
Given that negative perceptions of others may underlie several personality
disorders, finding techniques to get people to see others more positively
could promote the cessation of behavior patterns associated with several
different personality disorders simultaneously, Wood says.
This research suggests that when you ask someone to rate the personality
of a particular coworker or acquaintance, you may learn as much about
the rater providing the personality description as the person they are
describing. The level of negativity the rater uses in describing the
other person may indeed indicate that the other person has negative
characteristics, but may also be a tip off that the rater is unhappy,
disagreeable, neurotic -- or has other negative personality traits.
Raters in the study consisted of friends rating one another, college
freshmen rating others they knew in their dormitories, and fraternity
and sorority members rating others in their organization. In all samples,
participants rated real people and the positivity of their ratings were
found to be associated with the participant's own characteristics.
By evaluating the raters and how they evaluated their peers again one
year later, Wood found compelling evidence that how positively we tend
to perceive others in our social environment is a highly stable trait
that does not change substantially over time.
So again I ask you to challenge your thought process and remember conceive
it, believe it, achieve it! You can do whatever you put your mind to!
Meth Admissions Go Down Thanks To With Drug Control Efforts
Source: Medical News Today/Addiction Journal
A study published in the scientific journal Addiction shows that the
Mexican government's recent efforts to control the manufacture of methamphetamine
have caused a drop in methamphetamine treatment admissions in Mexico
and in neighbouring Texas. In 2005 Mexico began controlling its imports
of pseudoephedrine (a precursor chemical used in the manufacture of
methamphetamine), and in 2008 it became the first country in North America
to ban all imports of pseudoephedrine as well as ephedrine, another
important precursor chemical. Researchers estimate that the 2005 import
controls caused a 12% drop in voluntary methamphetamine treatment admissions
in Mexico, with similar reductions in Texas. An even larger drop in
voluntary admissions occurred following the 2007 closure of a commercial
chemical company suspected of illicitly importing more than 60 tons
of pseudoephedrine into Mexico. The head of the company fled Mexico
but was eventually arrested in the United States. Methamphetamine treatment
admissions in Mexico decreased by 56% following the closure of the company,
with Texas showing similar results. All decreases in admissions appeared
to be specific to methamphetamine, as researchers found no concurrent
changes in cocaine, heroin, and alcohol treatment admissions during
the same period. The study wound up shortly after the 2008 bans on precursor
chemicals came into effect, so researchers weren't able to examine fully
the impact of those bans; however, the researchers noted that treatment
admissions in Mexico showed signs of declining in the first few months
following the bans. Says lead researcher James Cunningham, a Fulbright
Scholar at The University of Arizona: "These findings constitute
the first evidence outside the United States that a country's precursor
chemical controls can have positive public health results both domestically
and internationally."